ACHE and Alzheimer disease: designed, synthesised, and evaluated a series of 6-substituted 3-arylcoumarin derivatives as dual AChE/MAO-B dual inhibitors for the treatment of AD, which provided meaningful information for further development of multifunctional drugs for AD treatment.